Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, MVolume:
5
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2015.27
Date:
April, 2015
File:
PDF, 1.35 MB
english, 2015